PDCD1 and neoplasm: These findings have represented a breakthrough in the immuno-oncology field, leading to the understanding that tumor infiltrating T-cells are often functionally impaired due to high expression of PD-1 levels, while malignant cells can escape immune surveillance by expressing PD-L1 (77).